BMI challenges the common belief that there are not enough transplantable organs to meet the demand. The Company redefines the problem as a “shortage of confirmed viable organs available for transplant”—not simply a shortage of organ donors. Understanding this distinction inspired BMI to develop CaVESWave®, which we believe is the most significant technological advances in the field of tissue perfusion in the past 40 years!
Pre-clinical testing demonstrated that CaVESWave® preserves organs longer than does current technology, and that it provides real-time organ metrics. Pre-clinical testing also validated that theCaVESWave® system not only keeps organs “alive” and fully-functional after being explanted, but it provides detailed, real-time organ performance and viability data, previously unavailable! This science may help eliminate unnecessary deaths in those patients waiting for organs!